Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Elevance Health, Inc. (ELV : NYSE)
 
 • Company Description   
Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana.

Number of Employees: 104,200

 
 • Price / Volume Information   
Yesterday's Closing Price: $340.67 Daily Weekly Monthly
20 Day Moving Average: 1,690,582 shares
Shares Outstanding: 225.93 (millions)
Market Capitalization: $76,969.14 (millions)
Beta: 0.60
52 Week High: $567.26
52 Week Low: $335.17
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.41% -15.41%
12 Week -19.75% -32.28%
Year To Date -7.65% -13.23%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
220 VIRGINIA AVENUE
-
INDIANAPOLIS,IN 46204
USA		 ph: 833-401-1577
fax: 317-488-6275		 investor.relations@elevancehealth.com http://www.elevancehealth.com
 
 • General Corporate Information   
Officers
Gail K. Boudreaux - Chief Executive Officer;President
Elizabeth E. Tallett - Chair of the Board
Peter D. Haytaian - President;Executive Vice President
Mark B. Kaye - Chief Financial Officer;Executive Vice President
Ronald W. Penczek - Chief Accounting Officer and Controller

Peer Information
Elevance Health, Inc. (CHCR)
Elevance Health, Inc. (ESRX)
Elevance Health, Inc. (MYDP)
Elevance Health, Inc. (COR)
Elevance Health, Inc. (GBCS)
Elevance Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 036752103
SIC: 6324
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/17/25
Share - Related Items
Shares Outstanding: 225.93
Most Recent Split Date: 6.00 (2.00:1)
Beta: 0.60
Market Capitalization: $76,969.14 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.01%
Current Fiscal Quarter EPS Consensus Estimate: $8.61 Indicated Annual Dividend: $6.84
Current Fiscal Year EPS Consensus Estimate: $34.40 Payout Ratio: 0.20
Number of Estimates in the Fiscal Year Consensus: 19.00 Change In Payout Ratio: 0.01
Estmated Long-Term EPS Growth Rate: 11.43% Last Dividend Paid: 06/10/2025 - $1.71
Next EPS Report Date: 07/17/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 9.90
Trailing 12 Months: 9.93
PEG Ratio: 0.87
Price Ratios
Price/Book: 1.81
Price/Cash Flow: 8.69
Price / Sales: 0.42
EPS Growth
vs. Year Ago Period: 12.50%
vs. Previous Quarter: 211.72%
Sales Growth
vs. Year Ago Period: 14.83%
vs. Previous Quarter: 7.59%
ROE
06/30/25 - -
03/31/25 - 18.61
12/31/24 - 18.28
ROA
06/30/25 - -
03/31/25 - 6.80
12/31/24 - 6.72
Current Ratio
06/30/25 - -
03/31/25 - 1.43
12/31/24 - 1.45
Quick Ratio
06/30/25 - -
03/31/25 - 1.43
12/31/24 - 1.45
Operating Margin
06/30/25 - -
03/31/25 - 4.32
12/31/24 - 4.35
Net Margin
06/30/25 - -
03/31/25 - 3.23
12/31/24 - 3.38
Pre-Tax Margin
06/30/25 - -
03/31/25 - 4.23
12/31/24 - 4.47
Book Value
06/30/25 - -
03/31/25 - 188.64
12/31/24 - 178.62
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.66
12/31/24 - 0.71
Debt-to-Capital
06/30/25 - -
03/31/25 - 39.74
12/31/24 - 41.36
 

Powered by Zacks Investment Research ©